transcription activator-like effector nuclease (talen)- mediated clybl targeting enables enhanced...
TRANSCRIPT
![Page 1: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/1.jpg)
Transcription Activator-Like Effector Nuclease (TALEN)-Mediated CLYBL Targeting Enables
Enhanced Transgene Expression and One-Step Generation of Dual Reporter Human Induced
Pluripotent Stem Cell (iPSC) and Neural Stem Cell (NSC) Lines
Trevor Cerbini, Ray Funahashi, Yongquan Luo, Chengyu Liu, Kyeyoon Park, Mahendra Rao, Nasir Malik, Jizhong Zou
NIH Center for Regenerative Medicine
PLOS One, Jan 2015
![Page 2: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/2.jpg)
• Genome engineering in iPSCs: low transfection efficiency and high rate of apoptosis• Need for system to safely integrate transgenes efficiently – with high
transfection efficiency and large number of stable clones• Ideal safe harbor site (acc. to Papapetrou 2011): • >50kb from 5’ end of any gene• >300kb from cancer-related gene and microRNA• Location outside transcriptional units and ultraconserved regions
• CLBYL site: stable random integration transgene expression• Question: Can TALEN be used to integrate reporter transgenes
efficiently and safely at multiple loci in human iPSCs and NSCs?
![Page 3: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/3.jpg)
Transcription Activator-Like Effector Nuclease (TALEN)
![Page 4: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/4.jpg)
TALEN can be used to target the safe-harbor CLYBL gene
![Page 5: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/5.jpg)
CLYBL safe harbor enables heightened expression of transgenes
• 5-fold higher HaloTag expression at CLYBL site• 10-fold higher Nanoluc expression at CLYBL site• 5-fold higher copGFP expression in CLYBL targeted
clones
![Page 6: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/6.jpg)
Double safe harbor targeting achieved in human iPSCs
8-week differentiation
AAVS1
CLYBL
![Page 7: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/7.jpg)
Safe harbor targeting achieved in human NSCs
*random integration
Undifferentiated
Differentiated
AAVS1
CLYBL
![Page 8: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/8.jpg)
Global and local gene expression conserved after targeted integration
![Page 9: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/9.jpg)
Summary• Transgene integration allowed 10-fold higher expression in CLYBL site than
AAVS1 site• 38-79% iPSC and 44-90% NSC targeted knock-in of reporter cassettes at either
or both safe harbor sites• Simultaneous dual reporter knock in at dual safe harbors in iPSCs and NSCs • Maintained transgene expression and multipotency over long periods of time
and after differentiation into cardiomyocytes and neurons • Maintenance of gene expression in loci after transgene integration
Targeted gene-addition efficiencies in human iPSCs
![Page 10: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/10.jpg)
Table S1. Summary of safe-harbor targeted NSCs
![Page 11: Transcription Activator-Like Effector Nuclease (TALEN)- Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual](https://reader035.vdocuments.site/reader035/viewer/2022062719/56649ed95503460f94be86d9/html5/thumbnails/11.jpg)
Implications for Raphael/Duncan projectProcedure:1. Wash endolymph out of organ of corti and replace with perilymph2. Add furosemide to temporarily block K+ pumps 3. Add sodium caprate to break tight junctions 4. Inject stably expressing reporter stem cells5. Look for cell integration, differentiation, tumors